208 related articles for article (PubMed ID: 11363233)
1. Clinicians experiment with post-exposure drug pairs.
AIDS Alert; 1996 Feb; 11(2):16-7. PubMed ID: 11363233
[TBL] [Abstract][Full Text] [Related]
2. AZT studies reinforce benefits of combination.
AIDS Alert; 1995 Jan; 10(1):11-2. PubMed ID: 11362167
[TBL] [Abstract][Full Text] [Related]
3. 3TC/AZT: just another combination.
GMHC Treat Issues; 1995 Dec; 9(12):2. PubMed ID: 11362997
[TBL] [Abstract][Full Text] [Related]
4. Lamivudine (3TC) approved for combination use with AZT.
James JS
AIDS Treat News; 1995 Dec; (no 236):1-5. PubMed ID: 11363049
[TBL] [Abstract][Full Text] [Related]
5. CDC takes aggressive stance on postexposure prophylaxis. Centers for Disease Control and Prevention.
AIDS Alert; 1996 Jul; 11(7):73-5. PubMed ID: 11363547
[TBL] [Abstract][Full Text] [Related]
6. Back to the nukes.
Smart T
GMHC Treat Issues; 1996 Feb; 10(2):6-7. PubMed ID: 11363383
[TBL] [Abstract][Full Text] [Related]
7. Potent new AIDS drugs underscore promise of combination therapy.
AIDS Alert; 1996 Jan; 11(1):1-4. PubMed ID: 11363225
[TBL] [Abstract][Full Text] [Related]
8. AZT and 3TC.
Treat Rev; 1996 Apr; (no 21):4. PubMed ID: 11363395
[TBL] [Abstract][Full Text] [Related]
9. A closer look at 3TC. Interview by Mark Mascolini.
Rubin M
J Int Assoc Physicians AIDS Care; 1995 Jul; 1(6):21-5. PubMed ID: 11362724
[TBL] [Abstract][Full Text] [Related]
10. 3TC and AZT.
Treat Rev; 1995; (no 17):2. PubMed ID: 11362294
[TBL] [Abstract][Full Text] [Related]
11. [What should be done after needlestick injuries with possible HIV exposure?].
Marcus U
Fortschr Med; 1996 Feb; 114(4):23-4. PubMed ID: 8852682
[No Abstract] [Full Text] [Related]
12. A Lisbon traviata. Are clinicians ready to sing addio to monotherapy and libiamo to combinations?
Mascolini M
J Int Assoc Physicians AIDS Care; 1995 Sep; 1(8):10-20, 22. PubMed ID: 11362792
[TBL] [Abstract][Full Text] [Related]
13. 3TC: combination trial stopped early as clinical benefit shown.
James JS
AIDS Treat News; 1996 Aug; (no 252):5. PubMed ID: 11363752
[TBL] [Abstract][Full Text] [Related]
14. [Anti-HIV chemoprophylaxis for blood-exposure accidents].
Bouvet E; Casalino E
Ann Med Interne (Paris); 2000 Jun; 151(4):283-90. PubMed ID: 10922956
[TBL] [Abstract][Full Text] [Related]
15. Combination 3TC/AZT therapy shows promise.
AIDS Clin Care; 1995 Mar; 7(3):22. PubMed ID: 11362192
[TBL] [Abstract][Full Text] [Related]
16. Major protease inhibitor triple combination trial begins soon: CD4 under 200, AZT experienced, 3TC naive.
James JS
AIDS Treat News; 1995 Dec; (no 237):3. PubMed ID: 11363075
[TBL] [Abstract][Full Text] [Related]
17. PHS recommends preventive drugs for HIV exposures.
OR Manager; 1996 Aug; 12(8):1, 6. PubMed ID: 10161372
[No Abstract] [Full Text] [Related]
18. 3TC approved: now for the tough questions.
Mascolini M
J Int Assoc Physicians AIDS Care; 1995 Dec; 1(11):6-8. PubMed ID: 11363101
[TBL] [Abstract][Full Text] [Related]
19. CDC wants more input before updating post-exposure guidelines. Centers for Disease Control and Prevention.
AIDS Alert; 1996 Feb; 11(2):13-5. PubMed ID: 11363232
[TBL] [Abstract][Full Text] [Related]
20. Updated postexposure guidelines stress need for expert advice.
AIDS Alert; 1998 Jul; 13(7):73-5. PubMed ID: 11365585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
